Table of contents

Clinical and epidemiological research

• Extended report: Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA (6 May, 2010)

  J L Nam, K L Winthrop, R F van Vollenhoven, K Pavelka, G Valesini, E M A Hensor, G Worthy, R Landewé, J S Smolen, P Emery, M H Buch
• Extended report: Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis (6 May, 2010)

  R Knevel, M Schoels, T W J Huizinga, D Aletaha, G R Burmester, B Combe, R B Landewé, J S Smolen, T Sokka, D M F M van der Heijde
• Extended report: Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis (6 May, 2010)

  Monika Schoels, John Wong, David L Scott, Angela Zink, Pamela Richards, Robert Landewé, Josef S Smolen, Daniel Aletaha
• Extended report: Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis (6 May, 2010)

  Cécile Gaujoux-Viala, Josef S Smolen, Robert Landewé, Maxime Dougados, Tore K Kvien, Emilio Martin Mola, Marieke Scholte-Voshaar, Piet van Riel, Laure Gossec
• Extended report: Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis (6 May, 2010)

  S L Gorter, Johannes W Bijlsma, M Cutolo, J Gomez-Reino, M Kouloumas, J S Smolen, R Landewé
• Extended report: Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases (17 September, 2009)

  M C van der Goes, J W G Jacobs, M Boers, T Andrews, M A M Blom-Bakkers, F Buttgereit, N Caeyers, E H Choy, M Cutolo, J A P Da Silva, L Guillevin, M Holland, J R Kirwan, J Rovensky, K G Saag, G Severijns, S Webber, R Westhovens, J W J Bijlsma
• Extended report: Tumour necrosis factor α −308G→A polymorphism is not associated with response to TNFα blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis (4 December, 2009)

  Stephan Pavy, Erik J M Toonen, Corinne Miceli-Richard, Pilar Barrera, Piet L C M van Riel, Lindsey A Criswell, Xavier Mariette, Marieke J H Coenen
• Extended report: Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment (5 May, 2010)

  Rachael J L Tan, Laura J Gibbons, Catherine Potter, Kimme L Hyrich, Ann W Morgan, Anthony G Wilson, John D Isaacs, BRAGGSS, Anne Barton
• Extended report: Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis (1 July, 2009)

  Mark A Little, Peter Nightingale, C A Verburgh, Thomas Hauser, Kirsten De Groot, Caroline Savage, David Jayne, Lorraine Harper
• Extended report: Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study (5 July, 2009)

  S M M Verstappen, M F Bakker, A H M Heurkens, M J van der Veen, A A Kruize, M A W Geurts, J W J Bijlsma, J W G Jacobs
• Extended report: Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis (11 August, 2009)

  Anne Hinks, Steve Eyre, Xiayi Ke, Anne Barton, Paul Martin, Edward Flynn, Jon Packham, Childhood Arthritis Prospective Study (CAPS), UKRAG Consortium, BSPAR Study Group, Jane Worthington, Wendy Thomson
• Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive disease

  (20 August, 2009)

  James I Robinson, Jennifer H Barrett, John C Taylor, YEAR Consortium, Marc Naven, Diane Corscadden, BRAGGSS, Anne Barton, Anthony G Wilson, Paul Emery, John D Isaacs, Ann W Morgan
• Extended report: Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials (27 August, 2009)

  Josef S Smolen, Daniel Aletaha, Johannes C Grisar, Tanja A Stamm, John T Sharp
• Extended report: Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors (9 September, 2009)

  Susanne Juhl Pedersen, Inge Juul Sørensen, Kay-Geert A Hermann, Ole Rintek Madsen, Niels Tvede, Michael Sejer Hansen, Gorm Thamsborg, Lis Smedegaard Andersen, Ole Majgaard, Anne Gitte Loft, Jon Erlendsson, Karsten Asmussen, Julia S Johansen, Anne Grethe Jurik, Jakob Møller, Maria Hasselquist, Dorrit Mikkelsen, Thomas Skjødt, Annette Hansen, Mikkel Østergaard
• Extended report: Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis (4 December, 2009) Free

  Patrik Stolt, Abqariyah Yahya, Camilla Bengtsson, Henrik Källberg, Johan Rönnelid, Ingvar Lundberg, Lars Klareskog, Lars Alfredsson, the EIRA Study Group
• Extended report: Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk (16 March, 2010)

  Elizabeth W Karlson, Lori B Chibnik, Peter Kraft, Jing Cui, Brendan T Keenan, Bo Ding, Souyma Raychaudhuri, Lars Klareskog, Lars Alfredsson, Robert M Plenge
• Extended report: Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register (5 May, 2010)

  W G Dixon, K L Hyrich, K D Watson, M Lunt, BSRBR Control Centre Consortium, D P M Symmons
• Extended report: Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study (3 May, 2010)

  Vanessa Smith, Carmen Pizzorni, Filip De Keyser, Saskia Decuman, Jens T Van Praet, Ellen Deschepper, Alberto Sulli, Maurizio Cutolo
• Extended report: Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year (6 May, 2010)

  Anette Jørgensen, Kristian Stengaard-Pedersen, Ole Simonsen, Mogens Pfeiffer-Jensen, Christian Eriksen, Henning Bliddal, Niels Wisbech Pedersen, Søren Bødtker, Kim Hørslev-Petersen, Lennart Ørtoft Snerum, Niels Egund, Helle Frimer-Larsen
• Extended report: EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome (28 June, 2009)

  Raphaèle Seror, Philippe Ravaud, Simon J Bowman, Gabriel Baron, Athanasios Tzioufas, Elke Theander, Jacques-Eric Gottenberg, Hendrika Bootsma, Xavier Mariette, Claudio Vitali
• Extended report: The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis (3 May, 2010)

  Diane van der Woude, Silje W Syversen, Ellen I H van der Voort, Kirsten N Verpoort, Guro L Goll, Michael P M van der Linden, Annette H M van der Helm-van Mil, Désirée M F M van der Heijde, Tom W J Huizinga, Tore K Kvien, René E M Toes
• Extended report: Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept (6 May, 2010)

  M Pilar Lisbona, Joan Maymó, Javier Perich, Miriam Almirall, Jordi Carbonell
• Extended report: Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost (3 May, 2010)

  Annelies Boonen, Tjinta Brinkhuizen, Robert Landewé, Désirée van der Heijde, Johan L Severens
• Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study

  (5 May, 2010)

  Edward Keystone, Mark C Genovese, Lars Klareskog, Elizabeth C Hsia, Stephen Hall, Pedro C Miranda, Jacek Pazdur, Sang-Cheol Bae, William Palmer, Stephen Xu, Mahboob U Rahman
• Concise report: Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study (16 August, 2009)

  I Rua-Figueroa, O Arencibia-Mireles, M Elvira, C Erausquin, S Ojeda, F Francisco, A Naranjo, C Rodríguez-Gallego, I Garcia-Laorden, J Rodríguez-Perez, C Rodríguez-Lozano
• Concise report: High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis (17 September, 2009)

  Olga Kaloudi, Francesca Bandinelli, Emilio Filippucci, Maria Letizia Conforti, Irene Miniati, Serena Guiducci, Francesco Porta, Antonio Candelieri, Domenico Conforti, Genesio Grassiri, Walter Grassi, Marco Matucci-Cerinic
• Concise report: Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial (22 October, 2009)

  A Hartkamp, R Geenen, G L R Godaert, M Bijl, J W J Bijlsma, R H W M Derksen
• Concise report: Hepatoprotective effect of tumour necrosis factor α blockade in psoriatic arthritis: a cross-sectional study (22 October, 2009)

  Michael Seitz, Stephan Reichenbach, Burkhard Möller, Marcel Zwahlen, Peter M Villiger, Jean-Francois Dufour
• Concise report: Bone marrow lesions are related to dynamic knee loading in medial knee osteoarthritis (11 November, 2009)

  Kim L Bennell, Mark W Creaby, Tim V Wrigley, Kelly-Ann Bowles, Rana S Hinman, Flavia Cicuttini, David J Hunter
• Concise report: Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? (3 May, 2010)

  H Amital, Z Szekanecz, G Szücs, K Dankó, E Nagy, T Csépány, E Kiss, J Rovensky, A Tuchynova, D Kozakova, A Doria, N Corocher, N Agmon-Levin, V Barak, H Orbach, G Zandman-Goddard, Y Shoenfeld
• Extended report: Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate (3 May, 2010)

  Stanley B Cohen, Edward Keystone, Mark C Genovese, Paul Emery, Charles Peterfy, Paul Peter Tak, Matt Cravets, Tim Shaw, David Hagerty
• Concise report: Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study (2 February, 2010)

  Mary A De Vera, M Mushfiqur Rahman, Vidula Bhole, Jacek A Kopec, Hyon K Choi
• Concise report: Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study (7 April, 2010)

  Jiunn-Horng Kang, Yi-Hua Chen, Herng-Ching Lin
• Concise report: Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy (27 April, 2010)

  Johan Lorenzen, Svjetlana Lovric, Robert Krämer, Hermann Haller, Marion Haubitz